BSE filing, BSE: 541299. Summary written from the filing by ALFA Finder's alert engine.
Dr. Lalchandani Labs Ltd: key numbers
- Share price
- ₹6.95
- Market cap
- ₹6.02 Cr
- Revenue (annual)
- ₹4.19 Cr
- Net profit (annual)
- ₹0.06 Cr
- P/E (TTM)
- 94.7×Sector 52.8×
- Promoter holding
- 32.90%
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Dr. Lalchandani Labs Ltd
All →Dr. Lalchandani Labs Other Announcement
Dr Lalchandani Labs Ltd. received an extension from the Registrar of Companies to hold its AGM for FY 2025-26 by December 31, 2026.
Dr. Lalchandani Labs H2 FY26 Results: Net Loss of ₹0.1 Cr
Dr. Lalchandani Labs Ltd reported revenue from operations of ₹2.1 Cr (-8.7% YoY) and a net loss of ₹0.1 Cr for H2 FY26.
- Key figure
- Net loss ₹0.1 Cr
Dr. Lalchandani Labs Board Meeting Date
Dr Lalchandani Labs Limited postponed its May 30 board meeting to June 03, 2026. The delay allows for internal review of financial data before results approval.
Dr. Lalchandani Labs Capacity Expansion: ₹1 Cr Investment
Dr Lalchandani Labs opened a new strategic centre in Dwarka, Delhi. The facility targets a ₹1 Crore annual revenue contribution from local government employee residents.
- Value
- ₹1.00 Cr
Dr. Lalchandani Labs Board Meeting Date
Dr Lalchandani Labs scheduled a board meeting on May 30, 2026, to approve annual audited financial results. The trading window remains closed until June 1.
Dr. Lalchandani Labs Other Announcement
Dr Lalchandani Labs Ltd confirmed it does not meet the 'Large Corporate' criteria for FY 2025-26 under SEBI debt-raising norms. The company reported zero incremental borrowings and no mandatory debt-sourcing requirements as its long-term borrowings remain below the Rs. 1000 crore threshold.
Other debt & borrowing announcements
All →Neogen Chemicals Debt & Borrowing: ₹500 Cr
Neogen Chemicals approved in-principle a Rs 500 Crore corporate guarantee for Neogen Morita's borrowings, subject to shareholder approval. The company reports no adverse impact.
- Value
- ₹500.0 Cr
Satin Creditcare Network Debt & Borrowing: ₹1.83 Cr
Satin Creditcare paid Rs.1.83 Crore quarterly interest on its 10.40% April 2027 NCDs on 31 October 2026. The payment fulfils an existing debt obligation.
- Value
- ₹1.83 Cr
AAA Technologies Debt & Borrowing: ₹6 Cr
AAA Technologies approved an inter-corporate loan of up to Rs.6 Crore to Transaction Solutions International at 12% interest. Repayable on demand; share-pledge security is proposed.
- Value
- ₹6.00 Cr
Spandana Sphoorty Financial Debt & Borrowing: ₹12.5 Cr
Spandana Sphoorty partially redeemed Rs 12.50 Crore of its listed secured NCDs on 31 October 2026 by face-value redemption. Rs 200 Crore remains outstanding.
- Value
- ₹12.50 Cr
Spandana Sphoorty Financial Debt & Borrowing: ₹2.71 Cr
Spandana Sphoorty paid monthly interest of Rs 2.71 Crore across two listed secured NCD series on 30 October 2026, on time. Series-wise amounts were Rs 2.01 Crore and Rs 0.70 Crore.
- Value
- ₹2.71 Cr
Industrial Investment Trust Debt & Borrowing: ₹200 Cr
Industrial Investment Trust's board approved borrowing up to Rs. 200 Crore from banks, NBFCs and other lenders, within the Rs. 1,000 Crore shareholder limit. The enabling approval names no specific lender yet.
- Value
- ₹200.0 Cr